Lexaria Bioscience Corp. (LEXX) bonds
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.18−0.23 (-5.22%)
Close on Nov 17, 2026Market cap $103.61MP/E –Yield –
Debt
Borrowings on the balance sheet, May 31, 2026
Lexaria Bioscience reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Lexaria Bioscience's 10-Q for the period ended Nov 30, 2020
| Issue | Coupon | Carrying value |
|---|---|---|
| 3-year term loan | 5.00% | – |
| Canadian dollar loan | 0.00% | C$40.00K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?